Abstract Submission Guidelines

IMPORTANT DATE

Abstract Submission Deadline: 14 May 2021
Abstract Acceptance Announcement: 9 June 2021
Payment Deadline for Accepted Abstracts: 1 July 2021
Congress Date: 23 - 24 July 2021

AWARDS & PRIZES

  Young Investigator Award The Best Paper Award Poster Presentation Award
1st  Prize RM 1,000 RM 1,000 RM 150
2nd  Prize RM 750 RM 750 RM 150
3rd  Prize RM 500 RM 500 RM 150
4th  Prize RM 300 RM 300  
5th  Prize RM 300 RM 300  

Award Categories

1. Young Investigator Award (oral presentation):
The YIA is open to young doctors, dieticians, pharmacists aged 40 years and below as at 31 December 2021. Awards will be given based on innovation, originality and high impact on nephrology advances.

2. The Best Paper Award (oral presentation):
This award is open to paramedics, no age limit. Awards wil be given based on high-quality paper on nephrology research and clinical experiences.

3. Poster Presentation Award:
This award is open to all researches, no age limit. Awards will be given to submitted e-posters which have interesting research questions and findings in any related areas of nephrology.

The Prizes
The winners for all awards will be announced during the closing ceremony. Each winner will receive a certificate and cash prizes. The judges' decision will be final.

ELIGIBILITY CRITERIA

  1. All abstracts submitted must be in English.
  2. The abstract title should not exceed 200 characters.
  3. The abstract should not exceed 300 words, which should include headings for Introduction, Methods, Results and Conclusion.
  4. Abstracts should contain original material that has neither been published nor presented at another meeting at the time of submission. In addition, abstracts should not be submitted to meetings which take place before the MSN Congress  2021. Multiple abstracts based on the same study will be summarily rejected.
  5. Abstracts submitted must follow the abstract submission guidelines, instructions and required information as stated. 
  6. Authors of abstracts accepted for presentation MUST be registered delegates and be responsible for all expenses incurred in the production of their presentations, travel and accommodation during the Congress.
  7. Once an abstract is selected, at least one of the authors of the abstract MUST register for the congress. Payment for congress registration should reach the congress secretariat before 1 July 2021 to ensure that your abstracts will be published in the Congress Programme book, either electronically or printed.
  8. Please find further details on registration, fees and payments on the Registration page of the congress website.

ABSTRACT SUBMISSION GUIDELINES

  1. Abstracts can only be submitted electronically through the registration platform on the official Congress website, no hardcopy is required. 
  2. Please register and submit your abstract/s with or without payment.
  3. Please read the instructions carefully, as abstract submitted not according to these instructions will not be accepted. You may submit more than ONE abstract (please use the same email address).
  4. Abstracts must be submitted by 14 May 2021 @ 23:59 hrs (GMT+8). Late submissions will not be accepted.
  5. Your abstract will appear in print or electronically as submitted. Please ensure you check your data carefully before submitting.
  6. The presenting author will be the sole corresponding author accepted by the Congress and the primary one responsible for the contents of the study and will be deemed to have taken consent from all the co-authors of the study.
  7. All Presenting Authors will receive detailed presentation guidelines when their abstract has been accepted and closer to the Congress date.
  8. Upon successfully submitting your abstract, you will receive an acknowledgement email.
  9. All submitted abstracts will undergo a peer-review process by a panel of expert reviewers. Accepted abstracts will be selected for either oral or/and e-poster presentation. Oral presenters are required to submit the e-Poster as well. The oral presentation can be delivered in-person or pre-recorded as per registration. The Scientific Committee reserves the right to re-categorise any accepted abstract. The decision of the committee is final and irrevocable. 
  10. Notification of acceptance will be sent via email by 7 June 2021.
  11. Presenting Authors will receive detailed presentation guidelines via email.
  12. After the submission deadline, no correction/s to the abstract will be entertained.
  13. Judges’ decisions are final. No appeal will be entertained.
  14. All accepted abstracts will be incorporated in the Congress Programme book.

SUBMISSION INSTRUCTIONS

Category: Please select the category which BEST describes the content of your abstract. Categories are used for reviewing and indexing purposes. 
 
ABSTRACT FORMAT

Abstract Title:   ALL IN CAPITAL LETTERS.  The title is limited to 200 characters excluding spaces and should be brief and relevant.  Special characters should NOT be used in your title but spelt out instead (e.g. α should be written as alpha, β as beta). Only use standard abbreviations in the title.
 
Authors and Affiliations:  The first author listed must be the Presenting/Attending Author. Type the authors’ names in (first name - last name/surname) surname-last format and capitalised the first letter of each name;  according to the format and example given. Authors’ affiliation should contain the name of institution, city and country.  When more than one author is listed, use numbers (no need superscript) to match authors and institutions.  Capitalise words only as required.
 
Abstract body:

  • Structure: The abstract should have the following sub-headings: –
    • Introduction
    • Methodology
    • Results
    • Conclusions
  • Layout: Please fill in according to the sections provided. Do not include graphs, tables or illustrations in the abstract.
  • Word count: The abstract body is limited to a total of 300 words.
  • Only commonly accepted abbreviations should be used (e.g. OGTT, IGT, ACEI). Less widely recognised abbreviations may be used if introduced on first usage (e.g. ambulatory blood pressure monitoring, ABPM).
  • Only approved and generic (non-proprietary) drug names should be used.
  • Do NOT enter the title, authors, or grant information into the abstract body submission field.

Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be produced in the abstract/programme book exactly as submitted.

SCORE

Marks given for each abstract will be according to the following scheme:
  • Originality - Idea/Innovation
  • Objectives of the study/Research questions: Relevance to clinical practice
  • Methodology
  • Presentation of the results: Does it answer the research questions?
  • Conclusion: Appropriateness and relevance
  • Language and presentation

ABSTRACT CATEGORY

  1. Hemodialysis
  2. Peritoneal Dialysis
  3. Transplant
  4. Glomerulonephritis
  5. Basic Science 
  6. Nutrition 
  7. Pediatric Nephrology
  8. Mineral Bone Disease
  9. COVID-19 
  10. Others